Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
Gabriela A., Project Coordinator at UT Health San Antonio, shared a post on LinkedIn:
”The FDA’s recent approval of ‘Ezplaz’, the first-ever-dried plasma product licensed in the United States, marks a major advancement in trauma care, particularly for military, emergency response, and other austere environments where traditional blood products are difficult to store and transport.
This milestone highlights the growing momentum behind blood preservation research, including TRC4-supported work at UTAustin, where investigators are exploring innovative thin-film freeze-drying approaches that could help shape the future of blood product storage, transport, and use in austere environments.
It’s exciting to see innovations once considered aspirational become reality, while groundbreaking research across The University of Texas System continues to transform bold ideas into real-world solutions.”
Stay uodated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments